Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity.

Tomic J, White D, Shi Y, Mena J, Hammond C, He L, Miller RL, Spaner DE.

J Immunol. 2006 Mar 15;176(6):3830-9.

2.

Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells.

Spaner DE, Shi Y, White D, Mena J, Hammond C, Tomic J, He L, Tomai MA, Miller RL, Booth J, Radvanyi L.

Leukemia. 2006 Feb;20(2):286-95.

PMID:
16341037
3.

Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.

Decker T, Schneller F, Kronschnabl M, Dechow T, Lipford GB, Wagner H, Peschel C.

Exp Hematol. 2000 May;28(5):558-68.

PMID:
10812246
4.

Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells.

Jurlander J, Lai CF, Tan J, Chou CC, Geisler CH, Schriber J, Blumenson LE, Narula SK, Baumann H, Caligiuri MA.

Blood. 1997 Jun 1;89(11):4146-52.

5.
6.

Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.

Hammond C, Shi Y, Mena J, Tomic J, Cervi D, He L, Millar AE, Debenedette M, Schuh AC, Baryza JL, Wender PA, Radvanyi L, Spaner DE.

J Immunother. 2005 Jan-Feb;28(1):28-39.

PMID:
15614042
7.

Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype.

Gary-Gouy H, Sainz-Perez A, Marteau JB, Marfaing-Koka A, Delic J, Merle-Beral H, Galanaud P, Dalloul A.

J Immunol. 2007 Oct 1;179(7):4335-44.

8.

IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.

Sainz-Perez A, Gary-Gouy H, Gaudin F, Maarof G, Marfaing-Koka A, de Revel T, Dalloul A.

J Immunol. 2008 Nov 1;181(9):6051-60.

9.

Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.

Glaum MC, Narula S, Song D, Zheng Y, Anderson AL, Pletcher CH, Levinson AI.

J Allergy Clin Immunol. 2009 Jan;123(1):224-230.e4. doi: 10.1016/j.jaci.2008.09.018. Epub 2008 Nov 7.

PMID:
18995892
10.

Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL).

Rossmann ED, Lewin N, Jeddi-Tehrani M, Osterborg A, Mellstedt H.

Eur J Haematol. 2002 May;68(5):299-306.

PMID:
12144536
11.

Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.

Muzio M, Scielzo C, Bertilaccio MT, Frenquelli M, Ghia P, Caligaris-Cappio F.

Br J Haematol. 2009 Feb;144(4):507-16. doi: 10.1111/j.1365-2141.2008.07475.x. Epub 2008 Nov 19.

PMID:
19036098
12.

IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.

Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T, Inoue T, Sugimoto A, Motoda R, Yamasaki F, Nakamura S, Kibata M.

Exp Hematol. 2008 Feb;36(2):181-92. Epub 2007 Nov 26.

PMID:
18023521
13.
14.

Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.

Wolska A, Cebula-Obrzut B, Smolewski P, Robak T.

Leuk Lymphoma. 2013 Jun;54(6):1268-78. doi: 10.3109/10428194.2012.741233. Epub 2012 Nov 20.

PMID:
23078646
15.

Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia.

Biagi E, Rousseau R, Yvon E, Schwartz M, Dotti G, Foster A, Havlik-Cooper D, Grilley B, Gee A, Baker K, Carrum G, Rice L, Andreeff M, Popat U, Brenner M.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6916-23.

16.

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.

Rodriguez JM, Elias F, Montaner A, Flo J, Lopez RA, Zorzopulos J, Franco RJ, Lenial SP, Lopez Salón M, Pirpignani ML, Solimano J, Garay G, Riveros D, Fernandez J, Cacchione R, Dupont J.

Medicina (B Aires). 2006;66(1):9-16.

PMID:
16555722
17.

Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia.

Tomic J, Lichty B, Spaner DE.

Blood. 2011 Mar 3;117(9):2668-80. doi: 10.1182/blood-2010-05-285999. Epub 2011 Jan 4.

18.

Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J.

Robinson K, Vona-Davis L, Riggs D, Jackson B, McFadden D.

J Am Coll Surg. 2006 May;202(5):788-96.

PMID:
16648019
19.

Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.

Vilpo J, Tobin G, Hulkkonen J, Hurme M, Thunberg U, Sundström C, Vilpo L, Rosenquist R.

Eur J Haematol. 2005 Jul;75(1):34-40.

PMID:
15946308
20.

Toll-like receptor-7 tolerizes malignant B cells and enhances killing by cytotoxic agents.

Shi Y, White D, He L, Miller RL, Spaner DE.

Cancer Res. 2007 Feb 15;67(4):1823-31.

Supplemental Content

Support Center